Swoop MRI portable system licensed by Health Canada
December 15, 2021
GUILFORD, Conn. – Hyperfine Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, has announced the Health Canada licensing of Swoop as well as the commercial launch of the imaging system in Canada. The license of Swoop includes the recently FDA-cleared advanced reconstruction software using deep learning. With this license, the Swoop system is now available for purchase in Canada.
“This regulatory clearance in our third country is a significant milestone for Hyperfine, validating our technology and helping both Canadian patients and hospitals,” said Dave Scott, president and chief executive officer of Hyperfine. “Current MRI systems are limited by their size, cost and training requirements, especially in remote locations. By rethinking the MRI design, Swoop provides an easy-to-use, portable and affordable system, which can provide imaging beyond boundaries, wherever patients are. We believe our advanced disruptive technology will help bring great access to advanced diagnostic imaging at the point of care across North America.”
UpCare, a Toronto-based national distributor of innovative medical technologies, specializing in value creation for Canadian healthcare providers, will execute marketing, distribution, and sales of the Swoop system in the country.
“We are always looking for innovations that have the potential to improve patient outcomes, access to new technology and healthcare economics,” said Benoit Sai (pictured), co-founder and chief commercial officer of UpCare. “Hyperfine is truly leading the way with the Swoop portable MRI system, further strengthening our neurosciences ecosystem. With Swoop’s addition, UpCare’s expanded product portfolio can provide a comprehensive continuum of care from diagnostic to monitoring.”
The Hyperfine system is designed to provide rapid imaging to allow physicians to make diagnoses and determine treatment for patients regardless of income or location. Swoop is being used around the world to address some of the limitations of current imaging technologies and to make MRI more accessible. The system wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled by an off the shelf tablet.
The company’s Canadian expansion continues their plans for accelerated global commercial expansion, including the UK and Pakistan, through 2022.
About Hyperfine and the Swoop Portable MR Imaging System
Hyperfine is the groundbreaking medical device company that created the world’s first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. This portable MRI system produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. It can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by a tablet. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others. For more information, please visit http://www.hyperfine.io.